Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity

Immunogenetics. 2015 Sep;67(9):545. doi: 10.1007/s00251-015-0861-2.
No abstract available

Publication types

  • Published Erratum